芦荟与阿托伐他汀联用可改变宫颈癌细胞的骨膜增生蛋白表达、消除 EMT 表型并使细胞对辐射敏感

IF 2.2 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Journal of Herbal Medicine Pub Date : 2024-04-30 DOI:10.1016/j.hermed.2024.100873
P. Thomas , S. Sahoo , S. Mahajan , D.L. Hiremath , A.H. Udayashankara , S. Srivastava
{"title":"芦荟与阿托伐他汀联用可改变宫颈癌细胞的骨膜增生蛋白表达、消除 EMT 表型并使细胞对辐射敏感","authors":"P. Thomas ,&nbsp;S. Sahoo ,&nbsp;S. Mahajan ,&nbsp;D.L. Hiremath ,&nbsp;A.H. Udayashankara ,&nbsp;S. Srivastava","doi":"10.1016/j.hermed.2024.100873","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Resistance to chemoradiation therapy results in poor prognosis and relapse in a sizeable percentage of cervical cancer patients. Toxicities and long-term side effects associated with radiation also warrant the need for molecules that could sensitise cells to radiation therapy. Naturally-derived compounds are a reservoir of non-toxic, potentially effective radiosensitizers of therapy-resistant tumours. This study evaluates the antitumorigenic properties of Aloe vera extracts.</p></div><div><h3>Methods</h3><p>Phenotypic assays and biochemical experiments like flow cytometry, real-time quantitative PCR, immunofluorescent imaging, western blotting, migration, and wound-healing assays were used to determine the effect of Aloe vera on cervical cancer cell lines.</p></div><div><h3>Results</h3><p>While Aloe vera treatment caused no significant changes to proliferation, survival, and cell cycling profiles, the expression of periostin, a molecule known for its association with stem-like cancer cells, decreased significantly. Phenotypically, Aloe vera treatment led to diminished clonogenicity and migratory abilities. Finally, combinatorial treatment of cells with Aloe vera and atorvastatin (a pan-Rho GTPase inhibitor) before radiation therapy resulted in a marked decrease in cell survival.</p></div><div><h3>Conclusions</h3><p>Our findings prove that Aloe vera treatment leads to reduced expression of periostin and adversely affects self-renewal and migration. Importantly, this work provides evidence that Aloe vera, in combination with atorvastatin, could serve as potential radiosensitizers of cancer cells.</p></div>","PeriodicalId":56077,"journal":{"name":"Journal of Herbal Medicine","volume":"45 ","pages":"Article 100873"},"PeriodicalIF":2.2000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Aloe vera Alters Periostin Expression, Abolishes EMT Phenotype, and Sensitises Cells to Radiation in Conjunction With Atorvastatin in Cervical Cancer\",\"authors\":\"P. Thomas ,&nbsp;S. Sahoo ,&nbsp;S. Mahajan ,&nbsp;D.L. Hiremath ,&nbsp;A.H. Udayashankara ,&nbsp;S. Srivastava\",\"doi\":\"10.1016/j.hermed.2024.100873\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Resistance to chemoradiation therapy results in poor prognosis and relapse in a sizeable percentage of cervical cancer patients. Toxicities and long-term side effects associated with radiation also warrant the need for molecules that could sensitise cells to radiation therapy. Naturally-derived compounds are a reservoir of non-toxic, potentially effective radiosensitizers of therapy-resistant tumours. This study evaluates the antitumorigenic properties of Aloe vera extracts.</p></div><div><h3>Methods</h3><p>Phenotypic assays and biochemical experiments like flow cytometry, real-time quantitative PCR, immunofluorescent imaging, western blotting, migration, and wound-healing assays were used to determine the effect of Aloe vera on cervical cancer cell lines.</p></div><div><h3>Results</h3><p>While Aloe vera treatment caused no significant changes to proliferation, survival, and cell cycling profiles, the expression of periostin, a molecule known for its association with stem-like cancer cells, decreased significantly. Phenotypically, Aloe vera treatment led to diminished clonogenicity and migratory abilities. Finally, combinatorial treatment of cells with Aloe vera and atorvastatin (a pan-Rho GTPase inhibitor) before radiation therapy resulted in a marked decrease in cell survival.</p></div><div><h3>Conclusions</h3><p>Our findings prove that Aloe vera treatment leads to reduced expression of periostin and adversely affects self-renewal and migration. Importantly, this work provides evidence that Aloe vera, in combination with atorvastatin, could serve as potential radiosensitizers of cancer cells.</p></div>\",\"PeriodicalId\":56077,\"journal\":{\"name\":\"Journal of Herbal Medicine\",\"volume\":\"45 \",\"pages\":\"Article 100873\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Herbal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2210803324000307\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Herbal Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210803324000307","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

导言对化学放疗的耐药性导致预后不良,相当比例的宫颈癌患者会复发。与放射治疗相关的毒性和长期副作用也使得人们需要能使细胞对放射治疗敏感的分子。天然萃取的化合物是一种无毒、可能有效的抗肿瘤放射增敏剂。本研究评估了芦荟提取物的抗肿瘤特性。方法采用表型测定和生化实验,如流式细胞术、实时定量 PCR、免疫荧光成像、Western 印迹、迁移和伤口愈合实验,来确定芦荟对宫颈癌细胞株的影响。结果虽然芦荟处理对细胞的增殖、存活和细胞周期特征没有造成显著变化,但因与干样癌细胞相关而闻名的分子--骨膜蛋白的表达却显著下降。从表型上看,芦荟处理导致克隆生成和迁移能力减弱。最后,在放疗前用芦荟和阿托伐他汀(一种泛Rho GTP酶抑制剂)联合处理细胞,会导致细胞存活率明显下降。重要的是,这项工作提供了芦荟与阿托伐他汀联用可作为潜在的癌细胞放射增敏剂的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Aloe vera Alters Periostin Expression, Abolishes EMT Phenotype, and Sensitises Cells to Radiation in Conjunction With Atorvastatin in Cervical Cancer

Introduction

Resistance to chemoradiation therapy results in poor prognosis and relapse in a sizeable percentage of cervical cancer patients. Toxicities and long-term side effects associated with radiation also warrant the need for molecules that could sensitise cells to radiation therapy. Naturally-derived compounds are a reservoir of non-toxic, potentially effective radiosensitizers of therapy-resistant tumours. This study evaluates the antitumorigenic properties of Aloe vera extracts.

Methods

Phenotypic assays and biochemical experiments like flow cytometry, real-time quantitative PCR, immunofluorescent imaging, western blotting, migration, and wound-healing assays were used to determine the effect of Aloe vera on cervical cancer cell lines.

Results

While Aloe vera treatment caused no significant changes to proliferation, survival, and cell cycling profiles, the expression of periostin, a molecule known for its association with stem-like cancer cells, decreased significantly. Phenotypically, Aloe vera treatment led to diminished clonogenicity and migratory abilities. Finally, combinatorial treatment of cells with Aloe vera and atorvastatin (a pan-Rho GTPase inhibitor) before radiation therapy resulted in a marked decrease in cell survival.

Conclusions

Our findings prove that Aloe vera treatment leads to reduced expression of periostin and adversely affects self-renewal and migration. Importantly, this work provides evidence that Aloe vera, in combination with atorvastatin, could serve as potential radiosensitizers of cancer cells.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Herbal Medicine
Journal of Herbal Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
3.90
自引率
0.00%
发文量
94
期刊介绍: The Journal of Herbal Medicine, the official journal of the National Institute of Medical Herbalists, is a peer reviewed journal which aims to serve its readers as an authoritative resource on the profession and practice of herbal medicine. The content areas of the journal reflect the interests of Medical Herbalists and other health professionals interested in the clinical and professional application of botanical medicines. The objective is to strengthen the research and educational base of herbal medicine with research papers in the form of case studies, original research articles and reviews, monographs, clinical trials and relevant in vitro studies. It also publishes policy statements, opinion pieces, book reviews, conference proceedings and profession related information such as pharmacovigilance reports providing an information source for not only the Herbal Practitioner but any Health professional with an interest in phytotherapy.
期刊最新文献
Group B Strep During Pregnancy and Allium sativum L. The efficacy of flaxseed oil on non-alcoholic fatty liver disease: a randomised controlled trial Research progress and modern application analysis of chemical constituents and pharmacological effects of volatile oils in acrid Chinese medicines Clinical outcomes of hospitalised COVID-19 Omicron patients treated with traditional Chinese Medicine: A Retrospective Studymedicine: a retrospective study of a large medical centre in Shanghai, China Evaluating efficacy and safety of Saffron add-on treatment in improvement of motor and depressive symptoms of patients with Parkinson’s disease: A randomized, double-blind, placebo-controlled clinical trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1